How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
Association of Abnormal Left Ventricular Functional Reserve With Outcome in Heart Failure With Preserved Ejection Fraction
Heart Failure With Improved Ejection Fraction-Is it Possible to Escape One’s Past?
Heart Failure Outcomes With Volume-Guided Management
Association Between Functional Impairment and Medication Burden in Adults with Heart Failure
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HF
A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF)